Shares of ALK-Abelló A/S (OTC:AKBLF – Get Free Report) rose 2.1% on Monday . The company traded as high as $24.50 and last traded at $24.50. Approximately 5 shares were traded during trading, a decline of 99% from the average daily volume of 618 shares. The stock had previously closed at $24.00.
ALK-Abelló A/S Stock Up 2.1 %
The company’s 50 day moving average is $25.14 and its 200 day moving average is $22.68.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Read More
- Five stocks we like better than ALK-Abelló A/S
- The How And Why of Investing in Oil Stocks
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What is a Low P/E Ratio and What Does it Tell Investors?
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
